Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Involvement of ER Stress in Dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 Missense Mutations Shown by iPSC-Derived Oligodendrocytes.
Cost of disorders of the brain in Spain.
Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies.
Piet Mondrian's trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011.
Schwann cells in therapy of spinal cord injuries.
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
Method for the systematic reviews on occupational therapy and neurodegenerative diseases.
Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review.
Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials.
Immunosuppressive treatments in multiple sclerosis.
The clinical impact of cerebellar grey matter pathology in multiple sclerosis.
Higher burden of migraine compared to other neurological conditions: results from a cross-sectional study.
Mitochondrial dysfunction in central nervous system white matter disorders.
T cell deficiency in spinal cord injury: altered locomotor recovery and whole-genome transcriptional analysis.
Illuminating vitamin D effects on B-cells - the multiple sclerosis perspective.
The Brown Norway opticospinal model of demyelination: Does it mimic multiple sclerosis or neuromyelitis optica?
Chiasmal optic neuritis in a 4-year-old girl: a case report and review of the literature.
CD226 Gly307Ser association with multiple autoimmune diseases: A meta-analysis.
[Laquinimod is an oral drug with a marked neuroprotective effect for pathogenetic treatment of multiple sclerosis(review)].
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation.
The New Era of Multiple Sclerosis Therapeutics.
Increased Th17 response to myelin peptides in pediatric MS.
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells.
Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.
Aggregation of MBP in chronic demyelination.

Pages